Navigation Links
Stanford researchers publish review of US medical device regulation
Date:1/10/2008

the entire complex process of medical device innovation and how it can be improved for manufacturers, and more importantly, for patients.

The FDAs Center for Devices and Radiological Health (CDRH) is currently taking steps to improve the post-market surveillance, researchers note, including strengthening the condition of approval studies; improving medical device reporting; focusing on risk-based inspections; implementing third-party inspections; communicating risk/benefit information; and refining the FDAs communications strategy.

Distinction from Drug Regulation

In contrast to pharmaceuticals, medical devices are evaluated using a risk-based classification system that determines its regulatory pathway. Devices are placed into one of three classes: Class I devices, representing low-risk items such as examination gloves do not require performance standards; medium and high-risk devices (Classes II and III) such as infusion pumps and defibrillators follow specific regulatory requirements that vary substantially.

By using a risk-based system, said researchers, the FDA recognizes that some degree of risk is inherent in the development of devices, and further, that all hazards cannot be eliminated. There is often little or no prior experience on which to base judgments about safety and effectiveness; devices undergo performance improvement modifications during clinical trials; and results depend on the skill of the user.

Other key points from the review include:

  • Class III devices are subject to the most stringent controls and require pre-market approval (PMA) to ensure safety and effectiveness of the devices.

  • The PMA program and 510(K) pre-market notification program resemble the regulatory pathways often referred to by industry.

  • The FDA quality systems regulations (QSR) define in clear terms the specific requirements manufacturers need to follow in de
    '/>"/>

Contact: Michael Stewart
michael.stewart@gabbe.com
212-220-4444
InHealth: The Institute for Health Technology Studies
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related biology news :

1. Americans remain pessimistic about the environment, Stanford-AP survey finds
2. Stanford/Packard researchers find disease genes hidden in discarded data
3. Stanford researchers say climate change will significantly increase impending bird extinctions
4. Stanfords nanowire battery holds 10 times the charge of existing ones
5. Researchers identify proteins involved in new neurodegenerative syndrome
6. Texas researchers and educators head for Antarctica
7. MGH researchers describe new way to identify, evolve novel enzymes
8. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
9. U of MN researchers discover noninvasive diagnostic tool for brain diseases
10. U of Minnesota researchers discover noninvasive diagnostic tool for brain diseases
11. Researchers discover new strategies for antibiotic resistance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... 2009 - Scientists at VIB and Ghent University in ... treatment of septic shock, the major cause of death ... nitric oxide (NO) gas in mice with septic shock, ... animal,s organs showed much less damage, while their chances ... since it is generally assumed that nitric oxide is ...
(Date:12/15/2009)... in German ., Despite the fact ... globe, cultures vary as to how space is encoded ... egocentric terms such as ,left, right, front, back, to ... ,north, south, east, west, at all times for all ... "There is an snake by your Northern leg". Whether ...
(Date:12/15/2009)... This release is available in German ... use in predicting the future distribution of mammals. This ... niches of 140 indigenous European mammals. The researchers analysed ... as well as the phylogenetic information of the species. ... for closely related species, mammals seem to adapt fast ...
Breaking Biology News(10 mins):Septic shock: Nitric oxide beneficial after all 2More than a jump to the left 2Species distribution models are of only limited value for predicting future mammal distributions 2If Baby Is Breech Technology Might Help 53983 1If Baby Is Breech Technology Might Help 53983 2If Baby Is Breech Technology Might Help 53983 3Researchers Produce First Nationwide Study of Homeless in ERs 53978 1Researchers Produce First Nationwide Study of Homeless in ERs 53978 2Regular Yoga Practice Is Associated With Mindful Eating 4836 1Regular Yoga Practice Is Associated With Mindful Eating 4836 2Regular Yoga Practice Is Associated With Mindful Eating 4836 3Regular Yoga Practice Is Associated With Mindful Eating 4836 4
... in your arm, controlling movement -- whether it,s grasping a ... that potentially takes into account thousands of variables. , But ... possible to control a limb by stimulating groups of muscles ... it easier to restore muscle movements in people who have ...
... at Harvard School of Public Health (HSPH) and elsewhere ... the epidemic rise of obesity and type 2 diabetes ... health threats, experts from the Department of Nutrition at ... must take action to help Americans choose healthier drinks. ...
... Beach, a graduate student in Virginia Tech,s College ... Carson Award for Scientific Excellence from the U.S. ... at the agency,s White Sulphur Springs National Fish ... demonstrate superior scientific involvement and application to achieve ...
Other Biology News:Grouping muscles to make controlling limbs easier 2Nutrition experts propose new class of low-sugar drinks to help stem obesity and diabetes epidemics 2Nutrition experts propose new class of low-sugar drinks to help stem obesity and diabetes epidemics 3
(Date:12/14/2009)... THOUSAND OAKS, Calif., Dec. 14 Array ... Inc.(Nasdaq: AMGN ) today announced that they ... rights to Array,s small-molecule glucokinase activator program, including ... clinical trial in patients with Type 2 diabetes. ... agreement, Array will receive an upfront payment of ...
(Date:12/14/2009)... The third edition of ... published by the Infusion Nurses Society (INS), ... extravasation.(1) Anthracyclines are a group of chemotherapy ... have been used in the treatment of various ... ,, According to the INS publication: "In ...
(Date:12/14/2009)... Resources, one of the world,s leading research and ... that, owing to the launches of several new ... more than sevenfold from $790 million in 2008 ... States, France, Germany, Italy, Spain, the United Kingdom ... Atrial Fibrillation finds that a strong ...
(Date:12/11/2009)... SEATTLE, Dec. 11 Dendreon Corporation (Nasdaq: ... of its previously announced public offering have exercised ... 2,250,000 shares of common stock at the public ... exercise of the option increases the size of ... of common stock. Dendreon expects to receive ...
Breaking Biology Technology:Array BioPharma and Amgen Partner in Type 2 Diabetes 2Array BioPharma and Amgen Partner in Type 2 Diabetes 3Array BioPharma and Amgen Partner in Type 2 Diabetes 4Array BioPharma and Amgen Partner in Type 2 Diabetes 5Array BioPharma and Amgen Partner in Type 2 Diabetes 6Array BioPharma and Amgen Partner in Type 2 Diabetes 7Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3
... unique properties and industry-leading characteristics of these products. , ... ... new product name changes that signify its commitment to innovation and ... They remain the same quality products that Zeus customers have ...
... to Market and Technology Expansion in Presentation to InvestorsINDIANAPOLIS, ... of delivering beyond expectations was the focus of a ... and CEO of Dow AgroSciences. Dow AgroSciences is ... (NYSE: DOW ). Peribere spoke to ...
... 10 Johnson & Johnson Pharmaceutical Research & ... and Drug Administration (FDA) has asked for additional ... (sNDA) for RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection. The ... RISPERDAL(R) CONSTA(R) for adjunctive maintenance treatment to delay ...
Other Biology Technology:Zeus Announces Product Name Changes 2Dow AgroSciences Delivering Beyond Expectations 2Dow AgroSciences Delivering Beyond Expectations 3FDA Issues Complete Response Letter for RISPERDAL(R) CONSTA(R) for the Adjunctive Maintenance Treatment of Bipolar Disorder 2FDA Issues Complete Response Letter for RISPERDAL(R) CONSTA(R) for the Adjunctive Maintenance Treatment of Bipolar Disorder 3FDA Issues Complete Response Letter for RISPERDAL(R) CONSTA(R) for the Adjunctive Maintenance Treatment of Bipolar Disorder 4FDA Issues Complete Response Letter for RISPERDAL(R) CONSTA(R) for the Adjunctive Maintenance Treatment of Bipolar Disorder 5
Anti-Mouse Ly 6C.2 , Ascites (Clone 5075-3.6) (mouse IgG2b)...
b-Catenin (pSer675), phospho-specific...
Goat polyclonal to SIAH Interacting Protein ( Abpromise for all tested applications)....
Naked1 Antibody Shipping Temperature: HOT Storage Temperature: -20C...
Biology Products: